1. MedWatch safety information: Rituxan (rituximab). 2004, http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166521.htm ]. Access date: August 31, 2012, Oct
2. Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology. 2007, 45 (2): 507-539. 10.1002/hep.21513.
3. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW: Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008, 57 (RR-8): 1-20.
4. Lok ASF, McMahon BJ: AASLD Practice Guideline Update: Chronic Hepatitis B: Update. 2009, Available at: http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/Chronic_Hep_B_Update_2009%208_24_2009.pdf Accessed November 7, 2013.?(2009)
5. Practice guidelines in oncology: Prevention and treatment of cancer-related infections. 2009, http://www.nccn.org/professionals/physician_gls/pdf/infections.pdf ]. Access date: August 31, 2012